Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324765 · ClinicalTrials.gov registry record · Phase 2
Women Overcoming and Managing Adversity Now (WOMAN) Study
A Phase 2 study of PTSD and Posttraumatic Stress Disorder, sponsored by UConn Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT01324765 is a Phase 2 study of PTSD and Posttraumatic Stress Disorder that has completed, run by UConn Health. The registered enrollment target is 108 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01324765, a Phase 2 study of PTSD and Posttraumatic Stress Disorder, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to evaluate the efficacy of a two therapeutic models designed to enhance women's skills for managing reactive emotions in their current lives as well as to educate them about how using these skills can enhance their personal effectiveness and help them to gain control of post-traumatic stress reactions. The interventions adaptations of a manualized psychotherapy that has shown promise with adults with complex Posttraumatic Stress Disorder (PTSD) (Trauma Affect Regulation: Guide for Education and Therapy; TARGET) compared to a supportive group therapy (SGT) that has been found to have modest benefits with women survivors of childhood abuse (Wallis, 2002).
Conditions Studied
Interventions
- BEHAVIORAL TARGET
- BEHAVIORAL SGT
Study Locations (1)
Connecticut
- York Correctional Institution - Niantic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324765
The ClinicalTrials.gov registry entry for NCT01324765 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (64% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which TARGET is the first listed.
NCT01324765 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT01324765 about?
NCT01324765 is a clinical study titled "Women Overcoming and Managing Adversity Now (WOMAN) Study". The goal of the study is to evaluate the efficacy of a two therapeutic models designed to enhance women's skills for managing reactive emotions in their current lives as well as to educate them about how using these skills can enhance their personal effectiveness and help them to gain control of pos...
What is the current status of trial NCT01324765?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2009-01. Estimated completion is 2010-11.
What conditions does trial NCT01324765 study?
This clinical trial studies the following conditions: PTSD, Posttraumatic Stress Disorder.
What interventions are being tested in trial NCT01324765?
The interventions under investigation include: TARGET (BEHAVIORAL), SGT (BEHAVIORAL).
Who is sponsoring clinical trial NCT01324765?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01324765 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
RECRUITING · Phase 2
-
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder
RECRUITING · Phase 2
-
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
RECRUITING · Phase 2
-
Induction of Dreaming With EEG and Anesthesia for Post-traumatic Stress Disorder
RECRUITING · Phase 2
-
Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
RECRUITING · Phase 2
-
Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.